Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1953 1
1968 1
1969 2
1977 1
1982 1
1983 1
1985 1
1987 2
1988 1
1989 1
1991 3
1993 2
1994 2
1995 2
1996 3
1997 1
1998 3
1999 2
2000 2
2001 5
2002 6
2003 8
2004 8
2005 13
2006 11
2007 10
2008 8
2009 8
2010 3
2011 13
2012 9
2013 31
2014 58
2015 55
2016 43
2017 48
2018 47
2019 33
2020 28
2021 32
2022 21
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23839181

484 results

Results by year

Filters applied: . Clear all
Page 1
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.
Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M; Brimonidine Phase II Study Group. Fowler J, et al. Br J Dermatol. 2012 Mar;166(3):633-41. doi: 10.1111/j.1365-2133.2011.10716.x. Br J Dermatol. 2012. PMID: 22050040 Free PMC article. Clinical Trial.
Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.
Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM. Layton AM, et al. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28. J Eur Acad Dermatol Venereol. 2015. PMID: 26416154 Free PMC article. Clinical Trial.
MIRVASO (brimonidine tartrate) topical gel 0.33%.
Abramovits W, Prato A, Vincent KD, Scheinfeld N, Gupta AK. Abramovits W, et al. Skinmed. 2014 Jan-Feb;12(1):41-3. Skinmed. 2014. PMID: 24720083 No abstract available.
484 results